Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

TOI stock hub

The Oncology Institute, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TOIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

395.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TOI

In the news

Latest news · TOI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-58

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TOI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001799191
Company name	The Oncology Institute, Inc.
Country	United States
Country code	US
Cusip	68236X100
Employees	641
Employees Change	-184%
Employees Change Percent	-22.3
Enterprise value	$469.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Isin	US68236X1000
Last refreshed	2026-05-10
Market cap	$395.4M
Market cap category	Small-Cap
Price	$4
Price currency	USD
Rev Per Employee	851,425.9x
Sector	Healthcare
Sic	8011
Symbol	TOI
Website	https://theoncologyinstitute.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.61%
EV Sales Forward	0.72x
EV/Sales	0.86x
FCF yield	-6.51%
P/S ratio	0.72x
PS Forward	0.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.99%
EBITDA Margin	-4.75%
Gross margin	15.12%
Gross Profit	$82.5M
Gross Profit Growth	39.18%
Gross Profit Growth Q	35.17%
Gross Profit Growth3 Y	15.27%
Gross Profit Growth5 Y	15.52%
Net Income	$-30.1M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Pretax Margin	-8%
Profit Margin	-7.97%
Profit Per Employee	$-46,958
ROA	-12.3
Roa5y	-17.89
ROCE	-36.77
ROIC	-57.97
Roic5y	-129.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	45.49%
Cagr3y	99.97%
Cagr5y	-16.81%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth	35.37x
Revenue Growth Q	41.22x
Revenue Growth Quarters	20x
Revenue Growth Years	6x
Revenue Growth3 Y	25.89x
Revenue Growth5 Y	23.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$3.29
Assets	$168.2M
Cash	$30.3M
Current Assets	$116.9M
Current Liabilities	$79.4M
Debt	$104.9M
Equity	$-16.3M
Interest Coverage	-4.28
Liabilities	$184.5M
Long Term Assets	$51.4M
Long Term Liabilities	$105.2M
Net Cash	$-74.6M
Net Cash By Market Cap	$-18.86
Tangible Book Value	$-33.8M
Tangible Book Value Per Share	$-0.34
WACC	6.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	25.32
Net Working Capital	$14.6M
Quick ratio	1.13
Working Capital	$37.5M
Working Capital Turnover	$12.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-30.1%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	45.46%
200-day SMA	3.45
3Y total return	700%
50-day SMA	3.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-60.16%
All Time High	12.66
All Time High Change	-68.4%
All Time High Date	2021-12-27
All Time Low	0.13
All Time Low Change	3,092.34%
All Time Low Date	2024-11-21
ATR	0.24
Beta	0.36
Beta1y	1.36
Beta2y	1.58
Ch YTD	12.36
High	4.15
High52	4.88
High52 Date	2025-10-24
High52ch	-18.03%
Low	3.89
Low52	2.02
Low52 Date	2025-06-30
Low52ch	98.51%
Ma50ch	22.1%
Premarket Change Percent	-0.49
Premarket Price	$4.05
Premarket Volume	25,851
Price vs 200-day SMA	15.91%
RSI	63.9
RSI Monthly	58.79
RSI Weekly	58.93
Sharpe ratio	0.8x
Sortino ratio	1.42
Total Return	-30.1%
Tr YTD	12.36
Tr1m	24.22%
Tr1w	-1.23%
Tr3m	53.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	142,626,200x
Earnings Revenue Estimate Growth	36.61x
Operating Income	$-32.7M
Operating margin	-5.99
Price target	$6.67
Price Target Change	$66.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	80,886,534%
Float Percent	81.84%
Net Borrowing	-1,061,000
Shares Insiders	12.66%
Shares Institutions	39.12%
Shares Out	98,839,144
Shares Qo Q	0.34%
Shares Yo Y	30.1%
Short Float	9.98%
Short Ratio	4.06
Short Shares	8.17

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-30.5M
Average Volume	1,415,294.75x
Bv Per Share	-0.16
CAPEX	$-3.9M
Ch1m	24.22
Ch1w	-1.23
Ch1y	45.46
Ch3m	53.26
Ch3y	700
Ch5y	-60.16
Ch6m	12.84
Change	-1.72%
Change From Open	-1.23
Close	4.07
Days Gap	-0.49
Depreciation Amortization	6,776,000
Dollar Volume	9,793,260
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-32.7M
EBITDA	$-25.9M
EPS	$-0.37
F Score	3
FCF	$-25.7M
FCF EV Yield	-5.47x
FCF Per Share	$-0.26
Financing CF	16,269,000
Fiscal Year End	December
Founded	2,007
Goodwill	7,230,000
Income Tax	$-131,000
Investing CF	-3,914,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	3.41
Ma150ch	17.23%
Ma20	3.62
Ma20ch	10.53%
Net CF	-9,459,000
Next Earnings Date	2026-08-12
Open	4.05
Optionable	Yes
Position In Range	42.31
Ppne	33,217,000
Pre Close	4.07
Price Date	2026-05-08
Relative Volume	1.73x
Revenue	545,764,000x
SBC By Revenue	0.88x
Share Based Comp	4,779,000
Tax By Revenue	-0.02x
Tr6m	12.84%
Us State	California
Volume	2,448,315

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TOI pay a dividend?

Capital-return profile for this ticker.

Performance

TOI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TOI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+39.1%

Float: +81.8% of shares outstanding

Insider ownership

+12.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TOI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.9

Neutral momentum band

Price vs 200-day MA

+15.9%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

0.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TOI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TOI stock rating?

The Oncology Institute, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TOI analysis?

The full report lives at /stocks/TOI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TOI?

The latest report frames TOI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TOI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.